Andreas Halvorsen Slashes Meta, Trims High-Beta Bets

According to their latest 13F filings, Andreas Halvorsen’s Viking Global Investors LP made aggressive reductions across multiple high-profile holdings in Q2 2025, signaling a broad shift away from higher-beta growth stocks. The most dramatic cut came in Meta Platforms Inc. (META), where the fund pared back nearly its entire position.

Meta Platforms (META) – Biggest Reduction

• Shares: 265,499
• Change: ↓ –1,200,812 (Previously: 1,466,311)
• Value: $195.96M
• % Change: –81.89%

Viking slashed its META stake by almost 82%, marking the single largest reduction in its portfolio this quarter. Despite Meta’s push into AI infrastructure and a rebound in digital advertising, Halvorsen’s exit suggests a cautious stance on mega-cap tech valuations after a prolonged run-up.

---

Other Notable Trims

• Royalty Pharma (RPRX): –75.41%
• Carvana (CVNA): –57.79%
• Trevi Therapeutics (TRVI): –52.20%
• Nvidia (NVDA): –43.73%

Collectively, these sharp reductions reflect a portfolio repositioning away from higher-beta and cyclical growth names, potentially signaling caution amid a volatile macro backdrop.

---

Major Exits: A Clean Break from Blue Chips

Alongside the trims, Viking executed full exits from several marquee names. The largest disposals included:

• UnitedHealth Group (UNH): $1.12B stake eliminated
• Intuit (INTU): $1.05B stake eliminated
• Netflix (NFLX): $699M stake eliminated
• Chubb Limited (CB): $589M stake eliminated
• Intercontinental Exchange (ICE): $552M stake eliminated

These exits — all multibillion-dollar blue-chip or financial holdings — underscore a sweeping reallocation. By closing out healthcare, fintech, streaming, insurance, and market infrastructure leaders, Viking appears to be rotating capital out of mature compounders and into other opportunities.